JP4723857B2 - アクネの治療のためのｇｅ２２７０因子ａ３のアミド誘導体の使用 - Google Patents

アクネの治療のためのｇｅ２２７０因子ａ３のアミド誘導体の使用 Download PDF

Info

Publication number
JP4723857B2
JP4723857B2 JP2004512782A JP2004512782A JP4723857B2 JP 4723857 B2 JP4723857 B2 JP 4723857B2 JP 2004512782 A JP2004512782 A JP 2004512782A JP 2004512782 A JP2004512782 A JP 2004512782A JP 4723857 B2 JP4723857 B2 JP 4723857B2
Authority
JP
Japan
Prior art keywords
group
pharmaceutical composition
acne
medicament
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2004512782A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005529947A5 (enExample
JP2005529947A (ja
Inventor
アドリアーノ・マラバルバ
マルコ・カヴァレリ
ジョルジョ・モスコーニ
ダニエラ・ヤベス
ガブリエッラ・ロマノ
Original Assignee
ヴィキュロン ファーマシューティカルズ インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ヴィキュロン ファーマシューティカルズ インコーポレイテッド filed Critical ヴィキュロン ファーマシューティカルズ インコーポレイテッド
Publication of JP2005529947A publication Critical patent/JP2005529947A/ja
Publication of JP2005529947A5 publication Critical patent/JP2005529947A5/ja
Application granted granted Critical
Publication of JP4723857B2 publication Critical patent/JP4723857B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2004512782A 2002-06-17 2003-06-06 アクネの治療のためのｇｅ２２７０因子ａ３のアミド誘導体の使用 Expired - Fee Related JP4723857B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02013268 2002-06-17
EP02013268.4 2002-06-17
PCT/EP2003/005989 WO2003105881A1 (en) 2002-06-17 2003-06-06 Use of amide derivative of ge 2270 factor a3 for the treatment of acne

Publications (3)

Publication Number Publication Date
JP2005529947A JP2005529947A (ja) 2005-10-06
JP2005529947A5 JP2005529947A5 (enExample) 2006-10-19
JP4723857B2 true JP4723857B2 (ja) 2011-07-13

Family

ID=29724391

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004512782A Expired - Fee Related JP4723857B2 (ja) 2002-06-17 2003-06-06 アクネの治療のためのｇｅ２２７０因子ａ３のアミド誘導体の使用

Country Status (17)

Country Link
US (1) US7655676B2 (enExample)
EP (1) EP1553967B1 (enExample)
JP (1) JP4723857B2 (enExample)
KR (1) KR20050026401A (enExample)
AR (1) AR039682A1 (enExample)
AT (1) ATE509633T1 (enExample)
AU (1) AU2003242647B2 (enExample)
BR (1) BR0305070A (enExample)
CA (1) CA2489705C (enExample)
CY (1) CY1111734T1 (enExample)
DK (1) DK1553967T3 (enExample)
ES (1) ES2364269T3 (enExample)
NO (1) NO333162B1 (enExample)
PT (1) PT1553967E (enExample)
SI (1) SI1553967T1 (enExample)
TW (1) TWI329650B (enExample)
WO (1) WO2003105881A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR060977A1 (es) * 2006-05-31 2008-07-23 Novartis Ag Aminotiazoles y sus usos
EA200900816A1 (ru) 2006-12-20 2009-12-30 Новартис Аг Антибактериальные соединения и способы их получения
CA2688621A1 (en) 2007-06-04 2008-12-11 Novartis Ag Macrocycles and their uses
NZ585788A (en) 2007-12-12 2011-07-29 Novartis Ag Aminothiazoles and their uses
PT106679B (pt) 2012-11-27 2015-03-25 Hovione Farmaciencia Sa Formulações tópicas de tetraciclinas, sua preparação e usos
FR3004939B1 (fr) * 2013-04-26 2015-05-22 Oreal Huile essentielle de satureja montana a forte teneur en geraniol, et utilisation pour traiter les peaux grasses et/ou les defauts esthetiques associes
DE102013215828A1 (de) * 2013-08-09 2015-02-12 Beiersdorf Ag Gelförmiges Sonnenschutzmittel mit Fettalkoholen

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988009788A1 (en) * 1987-06-12 1988-12-15 Molecular Design International, Inc. Topical prodrugs for treatment of acne and skin diseases
LU86865A1 (fr) * 1987-05-06 1989-01-19 Oreal Nouveaux retinoates d'ammonium quaternaires,leur utilisation en cosmetique et en dermopharmacie
ES2066914T3 (es) 1989-07-04 1995-03-16 Lepetit Spa Factores a1, a2, a3 y h del antibiotico ge 2270.
JP2693859B2 (ja) 1990-09-28 1997-12-24 高砂香料工業株式会社 尋常性▲ざ▼瘡用皮膚外用剤
IL100572A (en) 1991-01-03 1997-01-10 Lepetit Spa Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them
JP2907640B2 (ja) 1992-06-29 1999-06-21 高砂香料工業株式会社 尋常性ざ瘡用皮膚外用剤
JP2937667B2 (ja) 1992-11-19 1999-08-23 高砂香料工業株式会社 尋常性ざ瘡用皮膚外用剤
ES2115424T3 (es) 1995-02-07 1998-06-16 Biosearch Italia Spa Derivados prolin-amidicos basicos de los antibioticos ge 2270 y similares a ge 2270.
DE69718442T2 (de) 1996-02-14 2003-04-30 Biosearch Italia S.P.A., Gerenzano Derivate des antibiotisch wirkenden faktors ge2270
AUPN892496A0 (en) * 1996-03-25 1996-04-18 Technical Consultancy Services Pty Limited Acne treatment
US6009225A (en) * 1998-05-26 1999-12-28 Ray; Craig D. Fiber optic drop splice closure and related methods

Also Published As

Publication number Publication date
TWI329650B (en) 2010-09-01
TW200402425A (en) 2004-02-16
AR039682A1 (es) 2005-03-09
US7655676B2 (en) 2010-02-02
CY1111734T1 (el) 2015-10-07
ES2364269T3 (es) 2011-08-30
SI1553967T1 (sl) 2011-07-29
AU2003242647A1 (en) 2003-12-31
PT1553967E (pt) 2011-08-01
NO20040662L (no) 2004-04-05
NO333162B1 (no) 2013-03-25
EP1553967B1 (en) 2011-05-18
US20070117825A1 (en) 2007-05-24
CA2489705C (en) 2012-08-14
WO2003105881A1 (en) 2003-12-24
HK1074402A1 (en) 2005-11-11
DK1553967T3 (da) 2011-08-29
ATE509633T1 (de) 2011-06-15
JP2005529947A (ja) 2005-10-06
KR20050026401A (ko) 2005-03-15
AU2003242647B2 (en) 2009-10-22
BR0305070A (pt) 2004-09-21
EP1553967A1 (en) 2005-07-20
CA2489705A1 (en) 2003-12-24

Similar Documents

Publication Publication Date Title
Jappe Pathological mechanisms of acne with special emphasis on Propionibacterium acnes and related therapy
US6046238A (en) Method for treating or preventing the spread of acne vulgaris
JP2005239705A (ja) 局所的抗菌性製剤
CZ282548B6 (cs) Farmaceutický přípravek
KR20060108693A (ko) 습진의 치료 방법
US20040171561A1 (en) Topical formulations for treatment of rosacea
US20140199413A1 (en) Melatonin and an antimicrobial or antibacterial agent for the treatment of acne
JP2003521510A (ja) 抗菌剤としてのレチノイドタイプの化合物の使用
JP2005529947A (ja) アクネの治療のためのｇｅ２２７０因子ａ３のアミド誘導体の使用
JP2000095683A (ja) 皮膚外用剤
US8394857B2 (en) 1-amino-alkylcyclohexane derivatives for the treatment of inflammatory skin diseases
PT1515710E (pt) Método de tratamento de rosácea por aplicação tópica de um derivado de ciclo-hexano
JP2005529947A5 (enExample)
WO2022230949A1 (ja) 皮膚組織の異常を改善するための組成物
US6054479A (en) Preservative compositions and methods for using the same
HK1074402B (en) Use of amide derivative of ge 2270 factor a3 for the treatment of acne

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060531

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060831

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091117

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100203

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100210

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100312

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101116

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110111

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110208

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110309

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110314

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110408

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140415

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4723857

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140415

Year of fee payment: 3

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140415

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees